Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-06 Nader Francois Director Grant or award · Stock Option (Right to Buy) +6,454 6,454
2026-05-06 Nader Francois Director Grant or award · Restricted Stock Units +4,185 4,185
2026-04-30 Nader Francois Director Exercise or conversion +12,174 32,781
2026-04-30 Nader Francois Director Exercise or conversion · Restricted Stock Units −12,174 0
2025-04-30 Nader Francois Director Grant or award · Stock Option (Right to Buy) +6,378 6,378
2025-04-30 Nader Francois Director Grant or award · Restricted Stock Units +12,174 12,174
2024-05-06 Nader Francois Director Grant or award · Stock Option (Right to Buy) +7,557 7,557
2023-05-03 Nader Francois Director Grant or award · Stock Option (Right to Buy) +6,134 6,134

Page 1 of 1 · 8 trades